163 related articles for article (PubMed ID: 2537355)
1. Recognition of HIV glycoprotein gp120 by T cells. Role of monocyte CD4 in the presentation of gp120.
Siliciano RF; Knall C; Lawton T; Berman P; Gregory T; Reinherz EL
J Immunol; 1989 Mar; 142(5):1506-11. PubMed ID: 2537355
[TBL] [Abstract][Full Text] [Related]
2. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.
Manca F; Fenoglio D; Valle MT; Li Pira G; Kunkl A; Ferraris A; Saverino D; Lancia F; Mortara L; Lozzi L
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):227-37. PubMed ID: 7540488
[TBL] [Abstract][Full Text] [Related]
3. Characterization of GP120 binding to CD4 and an assay that measures ability of sera to inhibit this binding.
Schnittman SM; Lane HC; Roth J; Burrows A; Folks TM; Kehrl JH; Koenig S; Berman P; Fauci AS
J Immunol; 1988 Dec; 141(12):4181-6. PubMed ID: 3264307
[TBL] [Abstract][Full Text] [Related]
4. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
[TBL] [Abstract][Full Text] [Related]
5. Characterization of CD4 glycoprotein determinant-HIV envelope protein interactions: perspectives for analog and vaccine development.
Farrar WL; Harel-Bellan A; Ferris DK
Crit Rev Immunol; 1988; 8(4):315-39. PubMed ID: 2850890
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 transmission and function of virus-infected monocytes/macrophages.
Mann DL; Gartner S; Le Sane F; Buchow H; Popovic M
J Immunol; 1990 Mar; 144(6):2152-8. PubMed ID: 1690236
[TBL] [Abstract][Full Text] [Related]
7. HIV env glycoprotein shares a cross-reacting epitope with a surface protein present on activated human monocytes and involved in antigen presentation.
Beretta A; Grassi F; Pelagi M; Clivio A; Parravicini C; Giovinazzo G; Andronico F; Lopalco L; Verani P; Buttò S
Eur J Immunol; 1987 Dec; 17(12):1793-8. PubMed ID: 2446880
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
[TBL] [Abstract][Full Text] [Related]
9. Antigen targeting to antigen-presenting cells enhances presentation to class II-restricted T lymphocytes.
Scardino A; Paroli M; De Petrillo G; Michel ML; Barnaba V
Immunology; 1994 Jan; 81(1):167-70. PubMed ID: 7907575
[TBL] [Abstract][Full Text] [Related]
10. T cells can present antigens such as HIV gp120 targeted to their own surface molecules.
Lanzavecchia A; Roosnek E; Gregory T; Berman P; Abrignani S
Nature; 1988 Aug; 334(6182):530-2. PubMed ID: 2841610
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection.
Weinhold KJ; Lyerly HK; Stanley SD; Austin AA; Matthews TJ; Bolognesi DP
J Immunol; 1989 May; 142(9):3091-7. PubMed ID: 2468713
[TBL] [Abstract][Full Text] [Related]
12. Fusion of human B cell lines with HIV-1 envelope-expressing T cells is enhanced by antigen-specific Ig receptors. Possible mechanism for elimination of gp120-specific B cells in vivo.
Golding H; Dimitrov DS; Blackburn R; Manischewitz J; Blumenthal R; Golding B
J Immunol; 1993 Mar; 150(6):2506-16. PubMed ID: 7680694
[TBL] [Abstract][Full Text] [Related]
13. Galactose receptors and presentation of HIV envelope glycoprotein to specific human T cells.
Manca F
J Immunol; 1992 Apr; 148(7):2278-82. PubMed ID: 1312106
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 envelope gp120 inhibits the monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation.
Wang JM; Ueda H; Howard OM; Grimm MC; Chertov O; Gong X; Gong W; Resau JH; Broder CC; Evans G; Arthur LO; Ruscetti FW; Oppenheim JJ
J Immunol; 1998 Oct; 161(8):4309-17. PubMed ID: 9780207
[TBL] [Abstract][Full Text] [Related]
15. Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor.
Callahan KM; Fort MM; Obah EA; Reinherz EL; Siliciano RF
J Immunol; 1990 May; 144(9):3341-6. PubMed ID: 1970352
[TBL] [Abstract][Full Text] [Related]
16. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding.
Clayton LK; Sieh M; Pious DA; Reinherz EL
Nature; 1989 Jun; 339(6225):548-51. PubMed ID: 2543930
[TBL] [Abstract][Full Text] [Related]
17. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
Brett SJ; Rhodes J; Liew FY; Tite JP
J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
[TBL] [Abstract][Full Text] [Related]
18. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
Xiao X; Kinter A; Broder CC; Dimitrov DS
Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
[TBL] [Abstract][Full Text] [Related]
19. A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.
Hussey RE; Richardson NE; Kowalski M; Brown NR; Chang HC; Siliciano RF; Dorfman T; Walker B; Sodroski J; Reinherz EL
Nature; 1988 Jan; 331(6151):78-81. PubMed ID: 2829023
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of CD4+ T cell function by the HIV envelope protein, gp120.
Diamond DC; Sleckman BP; Gregory T; Lasky LA; Greenstein JL; Burakoff SJ
J Immunol; 1988 Dec; 141(11):3715-7. PubMed ID: 2846691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
